OpenAI AI Updates: October 21, 2026

1. OpenAI Agrees to Acquire Orchestra Bio to Bring AI Operations to Life Sciences R&D

OpenAI. OpenAI announced it is acquiring Orchestra Bio, a company focused on AI-powered operations for life sciences research and development. According to OpenAI, the deal is meant to help biopharma teams speed up drug development and advance new treatments. OpenAI did not disclose financial terms in its announcement summary. The move follows OpenAI’s recent push into scientific research, including the GPT-Rosalind academic plan for research labs announced the previous week. Source